New JAMA Psychiatry Study Estimates $366.8 Billion Annual Cost of Schizophrenia with State-by-State Breakdown

A new study published in JAMA as conducted in collaboration by researchers at the Schizophrenia & Psychosis Action Alliance, Blue Persimmon Group, and Precision AQ, finds that schizophrenia’s economic burden spans healthcare, housing instability, & lost economic participation. Lead author Holly Krasa notes that “Behind every dollar figure is a person navigating fragmented systems without coordinated support.” The study tracks costs across multiple systems tied to state and federal budgets, including emergency and inpatient care, housing instability, disability and income support, justice system involvement, unemployment, and premature mortality. Many costs shift between individuals and public agencies rather than disappearing altogether. The Alliance summarizes the findings in several infographics and video on their website as well.